-+ 0.00%
-+ 0.00%
-+ 0.00%

Coeptis Therapeutics Announces Nasdaq Grants Approval For Post-Merger Listing Under 'ZSQR' Ticker; Coeptis-Z Squared Merger Expected To Close Q2 2026

Benzinga·04/07/2026 16:08:24
Listen to the news

The transaction remains subject to satisfaction of any remaining customary closing conditions, and there can be no assurance that such conditions will be satisfied.